NCT03363984View on ClinicalTrials.gov

Pharmacokinetic Interaction Between Midazolam and ID-082 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 27, 2017

Primary Completion Date

December 19, 2017

Study Completion Date

December 19, 2017

Conditions
Healthy
Interventions
DRUG

Midazolam

Single oral administration of 2 mg midazolam under fasted conditions/outside of meal times

DRUG

ID-082

Administration of ID-082 under fasted conditions/outside of meal times

Trial Locations (1)

CF48 4DR

Simbec Research Limited, Merthyr Tydfil

Sponsors
All Listed Sponsors
lead

Idorsia Pharmaceuticals Ltd.

INDUSTRY

NCT03363984 - Pharmacokinetic Interaction Between Midazolam and ID-082 in Healthy Subjects | Biotech Hunter | Biotech Hunter